by Dr Andrew Kuc
At 11pm on March 29th 2019 the United Kingdom will leave the European Union. Incredibly, with just six months to go, the manner of our leaving remains uncertain. If a deal on the Withdrawal Agreement is successfully reached and ratified by all parties then the UK will prolong its association with the EU in the form of a ‘standstill’ transition period. This would include continued enjoyment of the single market, the customs union, aviation agreements, and Euratom.
However, if no agreement is reached, or it is rejected by Parliament, the UK would face falling out of the European Union, thereby losing the benefits of membership immediately. The treaties would cease to apply.
In this article I address the implications of no-deal Brexit on medical radioisotopes - a narrow subject, but one that is of considerable importance and relevance to a great many UK patients.
Dame Athene Donald
If Brexit means the UK loses access to European Research Council (ERC) funds just how bad will this be for our science? I believe the loss will be immense and in ways that impact far more than simply on the cash flow. I have been a member of the ERC’s Scientific Council for the last six years. I have watched the ERC’s work with interest and admiration. I can only metaphorically weep at all that is in danger of being tossed aside if the Government cannot resolve our access to the funds and sort out all the other associated issues such as visas and the easy mobility of researchers (and their families). I know there are those who believe we can replicate the ERC system of awarding grants to excellent individuals and, as long as the cash is there, if it is a different, national programme think it won’t matter. I think such people fail to understand the web of excellence that the ERC programme promotes. Alone we will be less. In this post I will simply concentrate on the direct implications of any loss of ERC funds here, rather than many of the knock-on effects on people and mobility, exchange of ideas and everything that genuine internationalisation has brought us.Read more
It’s been a good summer for astronomy. We had the longest total eclipse of the Moon of the 21st century, the delight that is the Perseid meteor shower, and NASA’s Parker Solar Probe began its journey to the Sun. On the ground, the general assembly of the International Astronomical Union met in Vienna, bringing around 3,000 of the world’s leading astronomers together to push the boundaries of research. The assembly, a triennial conference dating back to 1922, is a visible demonstration of the international nature of science and how the biggest questions are posed and answered by collaboration across national boundaries.
Dr Mike Galsworthy, Programme Director, Scientists for EU
On 23 Aug 2018, the Government published their technical notes on what no-deal Brexit would mean for UK access to the Horizon 2020 programme. Here we analyse what that means.Read more
by Nick Paul
Since 1985 UK manufacturers, distributors, and suppliers have enjoyed the ability to sell their products in all EU member states without any impediment caused by national safety standards. One set of standards meant safe products and fair access everywhere. After “Brexit day” on March 29th 2019, UK manufacturers – and UK consumers – fall out of the system of the now-famous 'CE mark'.
Sir Fraser Stoddart
The UK is home to some of the most creative and talented scientists of our time. They cover the spectrum all the way from molecular biology to quantum physics. In the middle of that spectrum lies chemistry and materials science. Interacting with these core fundamental sciences are world-leading atomic and molecular nanotechnologists alongside engineers of all persuasions. My area is the creation of molecular machines, for which I shared the Nobel Prize in Chemistry in 2016. A major catalyst on my life’s journey from Edinburgh to Stockholm was when I first threw my laboratory door open to researchers from across Europe and let the talent flood in.
Our new staff have started! Please meet Nick & Kirsty.
You will recall that back in June, we started a crowdfund for two new roles. Well, we smashed the 30K crowdfunding mark and so immediately advertised for two 6-month posts; one at Scientists for EU and one at our spin-out campaign Healthier IN the EU.
Both of those positions were embedded with European Movement in order to build on our growing collaboration.
The Lords gave a drubbing to Mrs May yesterday on the Customs Union, as you may have noticed if you don’t solely watch BBC News.
But what has gone virtually unnoticed is that the government is in full retreat on the new EU Clinical Trials Directive. This enables novel medicines to be tested across the EU28.Read more
We received a simple question this Christmas Eve, "Trying to understand why you want Great Britain and Northern Ireland to stay in the EU?" As an end of year roundup, we thought we'd publish our response as an open letter. The EU is a boost to our universities, our NHS, our industries, our jobs, our peace and our economy. That's become pretty clear this year. Here's our summary of why we think the way we do.
Dear Mr Johnson,
I read with great interest your letter of 15 September to The Telegraph entitled My vision for a bold, thriving Britain enabled by Brexit. I was thrilled to see that you chose to highlight the potential of my research field of gene therapy on this document. Quoting your words:
The NHS is a national asset whose data banks record the dizzying range of diseases that our flesh is heir to. Freed from EU regimes – often cumbersome and hard to change – we will be able to accelerate our work on gene therapy – an infant science, now taking its first faltering steps, whose potential is gigantic. Britain is already at the forefront of this, and we can lengthen our lead.